期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
<i>Citrobacter rodentium</i>, a Gut Pathogen: The Yin and the Yang of Its Pathophysiology, Immunity and Clinical Manifestation in Mice
1
作者 Tania Rahman Md. Ferdous Seraj Md. Monirul Islam 《Advances in Microbiology》 2018年第9期699-718,共20页
Pathogenic strains of E. coli including enteropathogenic E. coli (EPEC), enterohemorrhagic E. coli (EHEC), enterotoxigenic E. coli (ETEC) are principle causes for diarrhoea in many parts of the globe. Citrobacter rode... Pathogenic strains of E. coli including enteropathogenic E. coli (EPEC), enterohemorrhagic E. coli (EHEC), enterotoxigenic E. coli (ETEC) are principle causes for diarrhoea in many parts of the globe. Citrobacter rodentium (C. rodentium), a gram negative bacterium, is a murine pathogen that also utilizes type III secretion system and similar virulence factors to EPEC and EHEC and forms comparable attaching/effacing lesions in the intestines as EPEC and EHEC. The infection caused by C. rodentium in mice is usually self-limiting and results in only minor systemic effects with higher mortality in some susceptible mouse strains. All these characteristics have made the bacteria a commonly used model to study host immune responses to pathogenic E. coli infection. In this review, we focus on the impact of virulence factors of the pathogen;different immune components involved in the immune response and summarize their role during C. rodentium infection. 展开更多
关键词 CITROBACTER rodentium Attaching and Effacing PATHOGEN Locus of ENTEROCYTE Effacement Transmissible Murine Colonic HYPERPLASIA Colitis Mucosal Immune Response
下载PDF
Exosome-based liquid biopsy in the management of hepatocellular carcinoma
2
作者 Aparna Jayachandran Sasidhar Venkata Manda +3 位作者 Ritu Shrestha Kim R.Bridle Prashanth Prithviraj Darrell H.G.Crawford 《Hepatoma Research》 2018年第8期48-59,共12页
Hepatocellular carcinoma (HCC) commonly presents at an advanced stage due to the lack of efficient early screening tools. Early, non-invasive biomarkers useful in the diagnosis and prognosis of HCC would be of signifi... Hepatocellular carcinoma (HCC) commonly presents at an advanced stage due to the lack of efficient early screening tools. Early, non-invasive biomarkers useful in the diagnosis and prognosis of HCC would be of significant benefit for HCC management. Development of exosome-based liquid biopsy as a non-invasive method for the management of HCC has gained much traction. Exosomes are small membranous vesicles secreted by most cell types including HCC cells. Exosomes serve as couriers for the intercellular transfer of important biomolecules, including, protein, nucleic acids and lipids to nearby and distant cells in the body. The molecular cargos carried by exosome have been described to play significant roles in cancer progression. Herein, we will dissect how HCC-derived exosomes confer aggressive traits such as tumour growth, invasion, immune remodelling and drug resistance to HCC cells. We review the current literature concerning exosomes as biomarkers in a diagnostic setting, evaluating their prognostic, predictive and monitoring capabilities. This review will highlight and discuss emerging research in the utility of exosome-based liquid biopsies therapeutic tools in HCC management. Here we will also focus on advances in exosome biology in preclinical studies. 展开更多
关键词 Hepatocellular carcinoma LIQUID BIOPSY EXOSOMES microRNA epithelial-to-mesenchymal transition cancer stem cell
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部